Phathom Pharmaceuticals, Inc. (PHAT)
9.82
-0.18
(-1.80%)
USD |
NASDAQ |
Jun 09, 16:00
9.82
0.00 (0.00%)
After-Hours: 19:18
Phathom Pharmaceuticals SG&A Expense (Quarterly) : 54.01M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 73.66M |
| Corcept Therapeutics, Inc. | 145.36M |
| Assertio Holdings, Inc. | 11.14M |
| Veru, Inc. | 4.073M |
| Johnson & Johnson | 6.034B |